Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1977 Aug 25;14(1):15-9.
doi: 10.1007/BF00399882.

Cerebral angiography with non-ionic (metrizamide) and ionic (meglumine metrizoate) watersoluble contrast media. A comparative study with double blind technic

Clinical Trial

Cerebral angiography with non-ionic (metrizamide) and ionic (meglumine metrizoate) watersoluble contrast media. A comparative study with double blind technic

I O Skalpe et al. Neuroradiology. .

Abstract

The adverse effects of cerebral angiography with metrizamide and meglumine metrizoate were compared in 20 patients for each contrast medium using a double blind technic. Deterioration of the EEG and bradycardial reactions were seen more often with meglumine metrizoate than with metrizamide and these differences were statistically significant. Metrizamide also had a shorter circulation time, less influence on the blood pressure and EMG than meglumine metrizoate, but these differences were not statistically significant. The clinical examinations showed no difference in the minor adverse effects. One patient had transient hemiparesis and dysarthria after angiography with meglumine metrizoate but no serious complications were seen in the others.

PubMed Disclaimer

References

    1. Acta Radiol Suppl. 1973;335:25-44 - PubMed
    1. Am J Roentgenol Radium Ther Nucl Med. 1971 Nov;113(3):527-37 - PubMed
    1. Acta Radiol Diagn (Stockh). 1968 Jul;7(4):331-6 - PubMed
    1. Acta Radiol Diagn (Stockh). 1974 May;15(3):250-6 - PubMed
    1. Acta Radiol Diagn (Stockh). 1970 Mar;10 (2):97-107 - PubMed

MeSH terms